Dimethylsulfoxide induces upregulation of tumor suppressor protein PTEN through nuclear factor-kappaB activation in HL-60 cells.

[1]  S. Collins,et al.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[2]  K. Takase,et al.  Reversible G1 arrest in the cell cycle of human lymphoid cell lines by dimethyl sulfoxide. , 1990, Experimental cell research.

[3]  K. Takase,et al.  Reversible G1 arrest induced by dimethyl sulfoxide in human lymphoid cell lines: kinetics of the arrest and expression of the cell cycle marker proliferating cell nuclear antigen in Raji cells. , 1992, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[4]  A. Victor Hoffbrand,et al.  Co‐ordinated downregulation of bcl‐2 and bax expression during granulocytic and macrophage‐like differentiation of the HL60 promyelocytic leukaemia cell line , 1996, FEBS letters.

[5]  W. Cavenee,et al.  Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  Xuening Wang,et al.  Downregulation of telomerase activity in HL60 cells by differentiating agents is accompanied by increased expression of telomerase‐associated protein , 1997, Journal of cellular biochemistry.

[7]  M. Wigler,et al.  The lipid phosphatase activity of PTEN is critical for its tumor supressor function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[8]  José Luis de la Pompa,et al.  Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.

[9]  W. Cavenee,et al.  The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. , 1998, Cancer research.

[10]  B. Neel,et al.  A Role for Nuclear PTEN in Neuronal Differentiation , 2000, The Journal of Neuroscience.

[11]  A. Bloch,et al.  NF-κB (p65/RelA) as a regulator of TNFα-mediated ML-1 cell differentiation , 2001, Leukemia.

[12]  D. Stokoe,et al.  p27Kip1 is required for PTEN-induced G1 growth arrest. , 2001, Cancer research.

[13]  Michael P. Myers,et al.  PTEN controls tumor-induced angiogenesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. De,et al.  PTEN controls immunoreceptor (immunoreceptor tyrosine-based activation motif) signaling and the activation of Rac. , 2002, Blood.

[15]  Carlota Saldanha,et al.  Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. , 2003, Biochemical pharmacology.

[16]  M. Gorospe,et al.  PTEN expression in PTEN-null leukaemic T cell lines leads to reduced proliferation via slowed cell cycle progression , 2003, Oncogene.

[17]  M Zweyer,et al.  The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27Kip1 and control of cyclin D1 expression , 2003, Leukemia.

[18]  Kap-Seok Yang,et al.  Redox regulation of PTEN and protein tyrosine phosphatases in H2O2‐mediated cell signaling , 2004, FEBS letters.